Trovagene launches HPV assay – Pharmaceutical Business Review

Trovagene launches HPV assay
Pharmaceutical Business Review
Trovagene has commercially launched its urine-based HPV-HR (high-risk) assay, a molecular human papillomavirus (HPV) test. Using proprietary DNA sequences, the non-invasive molecular diagnostic test will identify the presence or absence of fifteen

View full post on hpv – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *